Loading...
*  NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients
NovaRx Corporation announced today that the company initiated its pivotal Phase III clinical trial of Lucanix(R) ( ... Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the ... NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients. Thursday, August 21, 2008 General News ... 21 NovaRx Corporation announced today thatthe company initiated its pivotal Phase III clinical trial of Lucanix(R)( ...
http://www.medindia.net/health-press-release/NovaRx-Initiates-Pivotal-Phase-III-Clinical-Trial-in-Lung-Cancer-Patients-29925-1.htm
*  Comparative determinants of 5-year cardiovascular event rates in patients with unprotected left main coronary artery disease.
Clinical Trials, Phase Iii As Topic. Comparative studies to verify the effectiveness of diagnostic, therapeutic, or ... Clinical Trials [8497 Associated Clinical Trials listed on BioPortfolio]. Predicting Physical Activity Change: an Epidemiologic ... This concept includes phase III studies conducted in both the U.S. and in other countries. ... Topics * All Topics Biotechnology Biotech Business Biotech Products Cancer Cardiovascular Dermatology Drug Discovery ...
https://www.bioportfolio.com/resources/pmarticle/1781426/Comparative-determinants-of-5-year-cardiovascular-event-rates-in-patients-with-unprotected.html
*  A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151...
Clinical Trials, Phase Iii As Topic. Comparative studies to verify the effectiveness of diagnostic, therapeutic, or ... Clinical Trial, Phase Iii. Work that is a report of a pre-planned, usually controlled, clinical study of the safety and ... Clinical Trials [16822 Associated Clinical Trials listed on BioPortfolio]. QUILT-2.023: A Study of ALT-803, a Fusion Protein ... Home » Topics » Melanoma » Research » A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With ...
https://www.bioportfolio.com/resources/pmarticle/2343903/A-Phase-Ib-Study-of-Pembrolizumab-as-Second-Line-Therapy-for-Chinese.html
*  Time trends in the demographics of patients randomized | Open-i
Time trends in the demographics of patients randomized in phase III trials.A good PS was defined as an Eastern Cooperative ... Clinical Trials, Phase III as Topic*. *Lung Neoplasms/drug therapy*/mortality*. *Small Cell Lung Carcinoma/drug therapy*/ ... pone-0042798-g002: Time trends in the demographics of patients randomized in phase III trials.A good PS was defined as an ... pone-0042798-g002: Time trends in the demographics of patients randomized in phase III trials.A good PS was defined as an ...
https://openi.nlm.nih.gov/detailedresult.php?img=PMC3412813_pone.0042798.g002&req=4
*  smoldering multiple myeloma drug therapy 2000:2010[pubdate] *count=100 - BioMedLib™ search engine
Clinical Trials, Phase II as Topic / statistics & numerical data. Clinical Trials, Phase III as Topic / statistics & numerical ... Clinical Conference. Clinical Trial, Phase I. Clinical Trial, Phase II. Clinical Trial, Phase III. Clinical Trial, Phase IV. ... Publication-type] Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial ... Publication-type] Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support ...
http://www.bmlsearch.com/?kwr=smoldering+multiple+myeloma+drug+therapy+2000:2010%5Bpubdate%5D&cxts=100&stmp=b1
*  DI-fusion Stemming resistance to HER-2 targeted therapy.
Clinical Trials, Phase III as Topic. Drug Resistance, Neoplasm. Humans. Neoplastic Stem Cells -- drug effects. ...
http://difusion.ulb.ac.be/vufind/Record/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/52340/Details
*  Efficacy and Safety Outcomes in Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab...
Clinical Trials, Phase II as Topic. Clinical Trials, Phase III as Topic ... Methods Data were pooled from phase II and III trials of patients who received nivolumab 1 mg/kg plus ipilimumab 3 mg/kg, every ... A Pooled Analysis of Randomized Phase II and III Trials.. ... All of ICR repositoryICR Divisions & RM Clinical UnitsIssue ... Purpose Approximately 40% of patients with advanced melanoma who received nivolumab combined with ipilimumab in clinical trials ...
https://repository.icr.ac.uk/handle/internal/1565
*  List of vaccine topics - Wikipedia
... placebo-controlled phase 2 clinical trial". The Lancet. 381 (9871): 1037-45. doi:10.1016/S0140-6736(12)61764-4. PMID 23352749. ... "Current Topics in Microbiology and Immunology. Current Topics in Microbiology and Immunology. 325: 361-382. doi:10.1007/978-3- ... List of vaccine topics. *#WHO-EM. *‡Withdrawn from market. *Clinical trials: *†Phase III ... "Inferring Reasons for the Failure of Staphylococcus aureus Vaccines in Clinical Trials". Frontiers in Cellular and Infection ...
https://en.wikipedia.org/wiki/List_of_vaccine_topics
*  The reporting of adverse events in oncology phase III trials: a comparison of the current status versus the expectations of the...
Clinical Trials, Phase III as Topic (MeSH) * Europe (MeSH) * Humans (MeSH) * Neoplasms (MeSH) ... The reporting of adverse events in oncology phase III trials: a comparison of the current status versus the expectations of the ... Frequencies of AEs leading to withdrawals were more frequently reported in trials funded by industry (P = 0.005) and in trials ... We assessed the reporting of key AEs in oncology randomized, controlled trials (RCTs) and compared that with the expectations ...
https://scholars.latrobe.edu.au/display/publication42160
*  Phase 3 Gene Therapy for Painful Diabetic Neuropathy - Full Text View - ClinicalTrials.gov
A number of clinical trials have established symptomatic treatment but for pathogenetic mechanisms, the only proven treatment ... See Studies by Topic. *See Studies on Map. *How to Search. *How to Use Search Results ... A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in ... Phase 3 Gene Therapy for Painful Diabetic Neuropathy. The safety and scientific validity of this study is the responsibility of ...
https://clinicaltrials.gov/ct2/show/NCT02427464
*  Phase III Trial of Febuxostat in Korea Gout Patients - Full Text View - ClinicalTrials.gov
MedlinePlus related topics: Gout Drug Information available for: Febuxostat U.S. FDA Resources ... Phase III Trial of Febuxostat in Korea Gout Patients. This study has been completed. ... participated in another investigational trial within the 30days prior to the screening visit ... 1.serum urate level ≥8.0mg/dL 2.creatinine level ≤ 1.5mg/dL 3.subject continued to meet all inclusion and no exclusion criteria ...
https://clinicaltrials.gov/ct2/show/NCT00821392
*  Topics - gou2016science
Hear about the exciting development of a new generation treatment from preclinical concept to a large phase III clinical trial ... A round up of the most important clinical trials in obstetrics running across the world ... Topics Carefully chosen topics - cutting edge science that will make you gasp. ... Hear about the EVERREST Trial from the lead author herself - a six million euro research trial.. ...
https://sites.google.com/site/gou2016science/scientific-program
*  Patient Reported Outcomes Burdens and Experiences - Phase 3 - Full Text View - ClinicalTrials.gov
Integrating the PROBE questionnaire in clinical trials, longitudinal studies, health technology assessment studies, routine ... Genetics Home Reference related topics: Hemophilia Genetic and Rare Diseases Information Center resources: Hemophilia ... In phase 1 of the study, the investigators developed the questionnaire. In phase 2 of the study, the investigators evaluated ... Patient Reported Outcomes Burdens and Experiences - Phase 3 (PROBE-3). The safety and scientific validity of this study is the ...
https://www.clinicaltrials.gov/ct2/show/NCT03549858
*  Update on Phase 3 Clinical Trials of Lanabecestat for Alzheimer's Disease | Benzinga
Update on Phase 3 Clinical Trials of Lanabecestat for Alzheimer's Disease Independent data monitoring committee advises ... Your weekly roundup of hot topics in the exciting world of fintech. ... Patients who completed the AMARANTH trial were given the opportunity to enroll in the AMARANTH extension trial, where all ... and the companies will now work with the clinical trial sites involved to implement the discontinuations. ...
https://www.benzinga.com/pressreleases/18/06/r11863440/update-on-phase-3-clinical-trials-of-lanabecestat-for-alzheimers-disea
*  Story: Masitinib Phase 3 Clinical Trial Update | ALS Therapy Development Institute
It was recently announced via press release from AB Sciences that their drug masitinib will continue to be trialed in ALS. What ... I write about the latest science in ALS and aim to provide a layman's overview of topics important to patients, caregivers, ... FIRST DRUG CANDIDATE FROM ALS THERAPY DEVELOPMENT INSTITUTE STARTS CLINICAL TRIAL. *Family Golf Tourney for ALS Donates $ ... FMI about the Clinical Trial: http://www.als.net/ALS-Research/174/ClinicalTrials/ ...
https://www.als.net/news/masitinib-phase-3-clinical-trial-update/
*  Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer. - MRC Weatherall Institute...
EXPERIMENTAL DESIGN: In the AVF2119g trial, 462 patients with MBC were randomly assigned to receive capecitabine or ... of novel putative biomarkers as predictors of benefit from bevacizumab in retrospective subset analyses of the AVF2119g trial. ... AVF2119g phase III trial). The aim of this study was to evaluate the expression ... Clinical Trials, Phase III as Topic, Deoxycytidine, Disease-Free Survival, Fluorouracil, Humans, Middle Aged, Neoplasm ...
https://www.imm.ox.ac.uk/publications/125317
*  NLNK) - NewLink Genetics Announces Phase 3 Clinical Trial of algenpantucel-L Immunotherapy | Benzinga
... multi-institutional Phase 3 study in patients with borderline resectable ... ... Your weekly roundup of hot topics in the exciting world of fintech. ... NewLink Genetics Announces Phase 3 Clinical Trial of algenpantucel-L Immunotherapy Charles Gross , Benzinga Staff Writer {{ ... If you have any questions as it relates to either of the three newsletters, please feel free to contact us at 1-877-440-ZING. ...
https://www.benzinga.com/news/12/10/2981469/newlink-genetics-announces-phase-3-clinical-trial-of-algenpantucel-l-immunotherap
*  Aldeyra Therapeutics Announces Results from Allergic Conjunctivitis Phase 2b Clinical Trial and Plans for Phase 3 Clinical...
NASDAQ: ALDX) (Aldeyra), a clinical-stage biotechnology company devoted to treating inflammation, inborn errors of metabolism, ... Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the ... scores during the late phase of ocular allergy observed in Phase 2a and Phase 2b clinical trials have confirmed the clinical ... Aldeyra Therapeutics Announces Results from Allergic Conjunctivitis Phase 2b Clinical Trial and Plans for Phase 3 Clinical ...
http://www.medindia.net/health-press-release/Aldeyra-Therapeutics-Announces-Results-from-Allergic-Conjunctivitis-Phase-2b-Clinical-Trial-and-Plans-for-Phase-3-Clinical-Testing-330903-1.htm
*  Graphical representation of the | Open-i
Clinical Trials, Phase II as Topic/methods/statistics & numerical data*. *Clinical Trials, Phase III as Topic/methods/ ... Clinical Trials, Phase II as Topic/methods/statistics & numerical data*. *Clinical Trials, Phase III as Topic/methods/ ... or continuation to phase III. Phase III incorporated two co-primary hypotheses, allowing for a treatment effect at either end ... or continuation to phase III. Phase III incorporated two co-primary hypotheses, allowing for a treatment effect at either end ...
https://openi.nlm.nih.gov/detailedresult.php?img=PMC3198122_10.1177_1740774511410582-fig1&req=4
*  NAVER Academic > Search...
Animals, Brain Ischemia, complications, Clinical Trials, Phase III as Topic, economics, Europe, Humans, Hypothermia, Induced, ... 2012 Chris Ham BMJ (Clinical research ed.) cited 0 times Delivery of Health Care, legislation & jurisprudence, England, Great ... 2012 Aser García Rada BMJ (Clinical research ed.) cited 0 times Bronchial Diseases, surgery, Cesarean Section, Female, Fetal ... 2012 Rory Watson BMJ (Clinical research ed.) cited 0 times ... 3 results for 'BMJ (Clinical research ed.) 344권 mar20 2호' ...
https://academic.naver.com/search.naver?field=3&query=BMJ+%28Clinical+research+ed.%29+344%EA%B6%8C+mar20+2%ED%98%B8
*  Cervical Cancer Treatment & Management: Approach Considerations, Stage-Based Therapy, Complications of Therapy
Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology ... Approval was based on the KEYNOTE-158 clinical trial (n=98). For the 77 patients whose tumors expressed PD-L1 with a CPS of 1 ... The safety of HPV vaccines is a deeply controversial topic. Follow-up of large patient populations who participated in phase 3 ... Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a ...
https://emedicine.medscape.com/article/253513-treatment
*  Teva's Phase III Migraine Clinical Trial Returns Positive Results - Xtalks
... treatment for migraine prevention was able to reduce the number of migraine days per month in a recent Phase III clinical trial ... Sign up for our newsletters and receive webinars, vitals and updates for your topic of choice.. *. First Name*. ... Clinical Trial News Sage's Postpartum Depression Drug Fares Well in Phase III Clinical Trial. November 13, 2017. ... Clinical Trial News Sage's Postpartum Depression Drug Fares Well in Phase III Clinical Trial. November 13, 2017. ...
https://xtalks.com/Teva-Phase-III-Migraine-Clinical-Trial-Results-802/
*  Keystone Symposia | Scientific Conferences on Biomedical and Life Science Topics
... conducts scientific conferences on biomedical and life science topics in relaxing environments that catalyze information ... Much progress has been made in recent years in this regard, and several phase III clinical trials testing various approaches to ... Remarkable clinical success of checkpoint inhibitors as well as adoptively transferred genetically engineered T cells further ... The challenge for next-generation vaccines is to resolve the discrepancy between the immune and clinical efficacy measured by ...
http://www.keystonesymposia.org/index.cfm?e=web.Meeting.Program&meetingid=1408
*  Phase II clinical trial of adjuvant chemotherapy with mFOLFOX6/XELOX for stage III colon cancer in Japanese subjects | ...
Topics * Anti-Cancer Agents & Biologic Therapy * Phase II clinical trial of adjuvant chemotherapy with mFOLFOX6/XELOX for stage ... 182P - Phase II clinical trial of adjuvant chemotherapy with mFOLFOX6/XELOX for stage III colon cancer in Japanese subjects. ... Clinical Trial Resources. ESMO Clinical Trial Resources are designed to support you with designing, participating in and ... Though, this clinical study was not randomized trial with small number of patients. ...
https://oncologypro.esmo.org/Topics/Anti-Cancer-Agents-Biologic-Therapy/Phase-II-clinical-trial-of-adjuvant-chemotherapy-with-mFOLFOX6-XELOX-for-stage-III-colon-cancer-in-Japanese-subjects